This site requires JavaScript to be enabled to work properly. Please modify your settings or use a different browser to continue

You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Service Provision for the COPD patient

Service Provision for the COPD patient; from COVID to the future


Summary

A panel of experts, Dr Graham Burns, Professor Sally Singh and Dr Christine Watson, will be sharing their pandemic experience and future expectations of service provision for patients with COPD.

Throughout the webinar, the panel will focus on:

- What has been the impact of COVID on COPD patients and what lessons have been learnt in secondary care?
- How have services for COPD needed to evolve?
- Planning for COPD services in the post-COVID future.

You can expect practical and informative advice on the implications on COVID-19 on COPD services.

Webinar Date | 6th May 2021 at 12:30 and 19:30

Speakers

NA

Dr Graham Burns

Respiratory Physician, Royal Victoria Infirmary Newcastle.
President of the British Thoracic Society.

Graham Burns began academic life as a mathematician before studying medicine. His clinical work (prior to the pandemic) has principally been in COPD and in asthma. He led on the Early Diagnostics pathway work stream with the NHS. At the start of the first wave of the COVID pandemic he set up his hospital's Respiratory Support (CPAP) Unit and designed the respiratory support escalations protocol, later published by the British Thoracic Society as a national guide. He also authored national guidance on shielding principles published by the BTS and referenced by the RCP and NHSE. Early after the first wave of the pandemic he set up a post-COVID Assessment Clinic with MDT review including physical and psychological components of the condition. This model formed the basis for the subsequent National Service Specification on which he was principle advisor to NHSE. Specialist advisor to NHSE Data, Analysis and Intelligence Service on resource planning for onward referral impact.

NA

Professor Sally Singh

Pulmonary and Cardiac Rehabilitation at the University
Hospitals of Leicester NHS Trust

Sally Singh is Professor of Pulmonary and Cardiac Rehabilitation at the University of Leicester. She is also Head of Pulmonary and Cardiac Rehabilitation at the University Hospitals of Leicester NHS Trust and Director of the Centre of Exercise and Rehabilitation Science, a multidisciplinary group of researchers conducting a range of research projects in the field of exercise and rehabilitation. She is PI for NIHR Global Research Group exploring culturally appropriate rehabilitation in low and middle income countries. She is the clinical lead for pulmonary rehabilitation as part of National Asthma and COPD Audit Programme (NACAP) and is the lead clinician for the Pulmonary Rehabilitation Service Accreditation Scheme run by the RCP. She co-chaired the American Thoracic Society / European Respiratory Society guidance on rehabilitation in the hospital and post-hospital phase from a European in the post COVID population.

NA

Dr Christine Watson

Critical Care Consultant and Deputy Head of Service for
Critical Care at Nottingham University Hospitals NHS Trust

Dr Christine Watson is a Consultant in Adult Critical Care at Nottingham University Hospitals NHS Trust. She is one of the Clinical Leads for Critical Care and the Critical Care Outreach Team within Nottingham and played a significant role in preparing the Trust for the COVID pandemic response. In addition, Christine is a member of the Women in Intensive Care Medicine Committee (WICM) a sub-committee of the Faculty of Intensive Care Medicine - a group of intensive care doctors working together across the UK to promote intensive care medicine as a career choice irrespective of gender. Dr Watson has an interest in Clinical Leadership and Management with particular emphasis on closing the gender gap within medical leadership.

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on +44 (0)800 221 441